Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Axon guidance | R-HSA-422475 | map04360 | Trolox C | 221071 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | Trolox C | 221071 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | Trolox C | 221071 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | Trolox C | 221071 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | Trolox C | 221071 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | clorsulon | 6307 | drug-path |
ErbB signaling pathway | R-HSA-168638 | map04012 | clorsulon | 6307 | drug-path |
Type II diabetes mellitus | R-HSA-2127377 | map04930 | clorsulon | 6307 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | clorsulon | 6307 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | etamivan | 9363 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | etamivan | 9363 | drug-path |
mTOR signaling pathway | R-HSA-165662 | map04150 | etamivan | 9363 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | etamivan | 9363 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | etamivan | 9363 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | etamivan | 9363 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | etamivan | 9363 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | etamivan | 9363 | drug-path |
Asthma | R-HSA-444620 | map05310 | etamivan | 9363 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | etamivan | 9363 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | etamivan | 9363 | drug-path |